Contact Us

Month: October 2020

Rare Thyroid Therapeutics and PledPharma to join forces
2020-10-27

Rare Thyroid Therapeutics and PledPharma to join forces

Read more
New publication on the unmet medical need in MCT8 deficiency
2020-06-17

New publication on the unmet medical need in MCT8 deficiency

Read more
Publication of positive results from the TRIAC-1 trial
2019-08-06

Publication of positive results from the TRIAC-1 trial

Read more
Emcitate granted US Orphan Drug status by the FDA
2019-01-18

Emcitate granted US Orphan Drug status by the FDA

Read more
Last patient completes the TRIAC-1 trial
2018-05-20

Last patient completes the TRIAC-1 trial

Read more
Emcitate® receives EU orphan drug designation
2017-10-16

Emcitate® receives EU orphan drug designation

Read more
TREAT-AHDS project elected for funding under the EUREKA-EUROSTARS framework
2017-06-18

TREAT-AHDS project elected for funding under the EUREKA-EUROSTARS framework

Read more
RTT and EMC enter into an exclusive licensing agreement
2017-04-01

RTT and EMC enter into an exclusive licensing agreement

Read more